|
|
 | | | |
- close
- close
- close
- close
Suggest other news sources for this topic
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/c/ce/IPO.jpg': No such file or directory @ blob.c/OpenBlob/2480. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/c/ce/IPO.jpg/40px-IPO.jpg' @ convert.c/ConvertImageCommand/2800. |
This company completed an initial public offering (IPO) of its stock in 2010. View articles that reference this company. Recent IPOs: Globe Specialty Metals • LogMeIn • Invesco Mortgage Capital • Medidata • Chemspec |
Proto Labs (NYSE:PRLB) manufactures parts quickly for companies with short-run productions or who are prototyping. In order to do this, Proto Labs uses manufacturing technologies such as computer numerical control (CNC), injection molding as well as 3D CAD designs. Rather than focus on large markets, Proto Labs serves the low-volume and relatively high margin manufacturing that often occurs in prototyping.[1]
Business Overview
For the full year 2011, Proto Labs reported a total revenue of $99M. This resulted in a net income of $18M. For the previous year, Proto Labs' total revenue was $65M and its net income was $11M.[2]
New Updates
The company's initial public offering of stock on the NYSE occurred on February 23, 2012. The company offered 4.3M shares each for $16. This was above the initial price range. The deal raised a total of $68.8M. The lead mangers of the deal were Jefferies and Piper Jaffray.[3]
Trends & Forces
Rise of 3D Printing
The growth of 3D printing in both consumer and industrial settings could impact Proto Labs. By focusing on prototyping, the company is exposed to the rise of alternate prototyping tools. As the price of 3D printers drops and their quality rises, consumers and companies will be able to build 3D printed prototypes relatively easily. This shift would cut into Proto Labs' margins. [4]
- ↑ PRLB S-1/A 2012 PROSPECTUS SUMMARY "Overview" p. 1-2
- ↑ PRLB S-1/A 2012 PROSPECTUS SUMMARY "Selected Consolidated Financial Data" p. 32
- ↑ Renaissance Capital - IPO Home "Proto Labs prices IPO at $16, above the range" 23 Feb 2012
- ↑ PRLB S-1/A 2012 PROSPECTUS SUMMARY "Risk Factors" p. 9-12
| |||||||
